Factors moderating the relative effectiveness of varenicline and nicotine replacement therapy in clients using smoking cessation services
ConclusionsVarenicline use is associated with higher smoking cessation rates than nicotine replacement therapy in routine clinical practice, irrespective of a wide range of smoker characteristics, but the difference is less in certain intervention settings, most notably pharmacy but also GP practice, compared with community setting.
Source: Addiction - Category: Addiction Authors: Neil Walker, Heather Gainforth, Vasiliki Kiparoglou, Hayley Robinson, Hugo Woerden, Robert West Tags: Research Report Source Type: research
More News: Addiction | Carbon Monoxide Poisoning | Chantix | General Practices | Nicotine | Nicotine Replacement Therapy | Primary Care | Smokers | Statistics